Eledon Pharmaceuticals (FRA:2TK) Other Long Term Assets : €0.19 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Eledon Pharmaceuticals Other Long Term Assets?

Eledon Pharmaceuticals's other long-term assets for the quarter that ended in Sep. 2024 was €0.19 Mil.

Eledon Pharmaceuticals's quarterly other long-term assets increased from Mar. 2024 (€0.17 Mil) to Jun. 2024 (€0.24 Mil) but then stayed the same from Jun. 2024 (€0.24 Mil) to Sep. 2024 (€0.19 Mil).

Eledon Pharmaceuticals's annual other long-term assets declined from Dec. 2021 (€0.35 Mil) to Dec. 2022 (€0.14 Mil) but then increased from Dec. 2022 (€0.14 Mil) to Dec. 2023 (€0.17 Mil).

Eledon Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Eledon Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eledon Pharmaceuticals Other Long Term Assets Chart

Eledon Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

0.57

0.32

0.35

0.14

0.17

Eledon Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long Term Assets	Get a 7-Day Free Trial															0.22	0.17	0.17	0.24	0.19

Eledon Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Eledon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eledon Pharmaceuticals Inc (FRA:2TK) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ELDN:USA 2TK:Germany

Address

19900 MacArthur Boulevard, Suite 550, Irvine, CA, USA, 92612

Website

https://www.eledon.com

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Eledon Pharmaceuticals Headlines

No Headlines